Zydus Lifesciences Growth Strategy
Zydus forecasts steady growth for five years as innovation matures.
The Economic Times · 1m
Zydus Targets New Growth Areas
Zydus Lifesciences plans to expand into specialty medicines and biologics while maintaining US generics.
The Economic Times · 1m
Bharat Biotech Returns to Innovation After Pandemic
Bharat Biotech founder Krishna Ella reveals post-Covid reset, TB vaccine progress, and future focus on Africa.
The Economic Times · 1m
Aragen bets big on complex drugs and IPO
Indian contract manufacturer plans 500 kilolitres of new capacity and moves into antibody-drug conjugates, peptides and oligonucleotides.
The Economic Times · 1m